Literature DB >> 32083953

BMP9/10 in Pulmonary Vascular Complications of Liver Disease.

Elizabeth R Rochon1, Michael J Krowka2, Sonja Bartolome3, Gustavo A Heresi4, Todd Bull5, Kari Roberts6, Anna Hemnes7, Kimberly A Forde8, Karen L Krok9, Mamta Patel8, Grace Lin2, Megan McNeil9,10, Nadine Al-Naamani8, Beth L Roman11, Paul B Yu9,12, Michael B Fallon12, Mark T Gladwin1, Steven M Kawut8.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32083953      PMCID： PMC7301744          DOI： 10.1164/rccm.201912-2514LE

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN： 1073-449X            Impact factor:   21.405


× No keyword cloud information.
  12 in total

1.  Diagnosis of portopulmonary hypertension in candidates for liver transplantation: a prospective study.

Authors:  Isabelle O Colle; Richard Moreau; Erica Godinho; Jacques Belghiti; Florence Ettori; Alain Cohen-Solal; Hervé Mal; Jacques Bernuau; Jean Marty; Didier Lebrec; Dominique Valla; François Durand
Journal:  Hepatology       Date:  2003-02       Impact factor: 17.425

Review 2.  Pulmonary arteriovenous malformations after the superior cavopulmonary shunt: mechanisms and clinical implications.

Authors:  Minoo N Kavarana; Jeffrey A Jones; Robert E Stroud; Scott M Bradley; John S Ikonomidis; Rupak Mukherjee
Journal:  Expert Rev Cardiovasc Ther       Date:  2014-04-23

3.  Bone Morphogenetic Protein 9 Is a Mechanistic Biomarker of Portopulmonary Hypertension.

Authors:  Ivana Nikolic; Lai-Ming Yung; Peiran Yang; Rajeev Malhotra; Samuel D Paskin-Flerlage; Teresa Dinter; Geoffrey A Bocobo; Kathleen E Tumelty; Anthony J Faugno; Luca Troncone; Megan E McNeil; Xiuli Huang; Kathryn R Coser; Carol S C Lai; Paul D Upton; Marie Jose Goumans; Roham T Zamanian; C Gregory Elliott; Arthur Lee; Wei Zheng; Stephen P Berasi; Christine Huard; Nicholas W Morrell; Raymond T Chung; Richard W Channick; Kari E Roberts; Paul B Yu
Journal:  Am J Respir Crit Care Med       Date:  2019-04-01       Impact factor: 21.405

4.  BMP9 is produced by hepatocytes and circulates mainly in an active mature form complexed to its prodomain.

Authors:  Marie Bidart; Nicolas Ricard; Sandrine Levet; Michel Samson; Christine Mallet; Laurent David; Mariela Subileau; Emmanuelle Tillet; Jean-Jacques Feige; Sabine Bailly
Journal:  Cell Mol Life Sci       Date:  2011-06-28       Impact factor: 9.261

5.  A heterodimer formed by bone morphogenetic protein 9 (BMP9) and BMP10 provides most BMP biological activity in plasma.

Authors:  Emmanuelle Tillet; Marie Ouarné; Agnès Desroches-Castan; Christine Mallet; Mariela Subileau; Robin Didier; Anna Lioutsko; Guillaume Belthier; Jean-Jacques Feige; Sabine Bailly
Journal:  J Biol Chem       Date:  2018-05-22       Impact factor: 5.157

6.  Pulse Oximetry Is Insensitive for Detection of Hepatopulmonary Syndrome in Patients Evaluated for Liver Transplantation.

Authors:  Kimberly A Forde; Michael B Fallon; Michael J Krowka; Michael Sprys; David S Goldberg; Karen L Krok; Mamta Patel; Grace Lin; Jae K Oh; Carl D Mottram; Paul D Scanlon; Steven M Kawut
Journal:  Hepatology       Date:  2018-12-18       Impact factor: 17.425

Review 7.  Normal and abnormal pulmonary arteriovenous shunting: occurrence and mechanisms.

Authors:  Julien I E Hoffman
Journal:  Cardiol Young       Date:  2013-03-05       Impact factor: 1.093

8.  Bone morphogenetic protein-9 is a circulating vascular quiescence factor.

Authors:  Laurent David; Christine Mallet; Michelle Keramidas; Noël Lamandé; Jean-Marie Gasc; Sophie Dupuis-Girod; Henri Plauchu; Jean-Jacques Feige; Sabine Bailly
Journal:  Circ Res       Date:  2008-02-28       Impact factor: 17.367

9.  Selective enhancement of endothelial BMPR-II with BMP9 reverses pulmonary arterial hypertension.

Authors:  Lu Long; Mark L Ormiston; Xudong Yang; Mark Southwood; Stefan Gräf; Rajiv D Machado; Matthias Mueller; Bernd Kinzel; Lai Ming Yung; Janine M Wilkinson; Stephen D Moore; Kylie M Drake; Micheala A Aldred; Paul B Yu; Paul D Upton; Nicholas W Morrell
Journal:  Nat Med       Date:  2015-06-15       Impact factor: 53.440

10.  Characterization of GDF2 Mutations and Levels of BMP9 and BMP10 in Pulmonary Arterial Hypertension.

Authors:  Joshua Hodgson; Emilia M Swietlik; Richard M Salmon; Charaka Hadinnapola; Ivana Nikolic; John Wharton; Jingxu Guo; James Liley; Matthias Haimel; Marta Bleda; Laura Southgate; Rajiv D Machado; Jennifer M Martin; Carmen M Treacy; Katherine Yates; Louise C Daugherty; Olga Shamardina; Deborah Whitehorn; Simon Holden; Harm J Bogaard; Colin Church; Gerry Coghlan; Robin Condliffe; Paul A Corris; Cesare Danesino; Mélanie Eyries; Henning Gall; Stefano Ghio; Hossein-Ardeschir Ghofrani; J Simon R Gibbs; Barbara Girerd; Arjan C Houweling; Luke Howard; Marc Humbert; David G Kiely; Gabor Kovacs; Allan Lawrie; Robert V MacKenzie Ross; Shahin Moledina; David Montani; Andrea Olschewski; Horst Olschewski; Willem H Ouwehand; Andrew J Peacock; Joanna Pepke-Zaba; Inga Prokopenko; Christopher J Rhodes; Laura Scelsi; Werner Seeger; Florent Soubrier; Jay Suntharalingam; Mark R Toshner; Richard C Trembath; Anton Vonk Noordegraaf; Stephen J Wort; Martin R Wilkins; Paul B Yu; Wei Li; Stefan Gräf; Paul D Upton; Nicholas W Morrell
Journal:  Am J Respir Crit Care Med       Date:  2020-03-01       Impact factor: 21.405
View more
  5 in total

1.  Implications of BMP9/10 for patients with liver cirrhosis.

Authors:  Dong Ji; Guofeng Chen; Yongping Yang
Journal:  EBioMedicine       Date:  2020-07-03       Impact factor: 8.143

2.  Reduced circulating BMP10 and BMP9 and elevated endoglin are associated with disease severity, decompensation and pulmonary vascular syndromes in patients with cirrhosis.

Authors:  Nicola E Owen; Graeme J Alexander; Sambit Sen; Katherine Bunclark; Gary Polwarth; Joanna Pepke-Zaba; Anthony P Davenport; Nicholas W Morrell; Paul D Upton
Journal:  EBioMedicine       Date:  2020-05-23       Impact factor: 8.143

3.  In Search of "Hepatic Factor": Lack of Evidence for ALK1 Ligands BMP9 and BMP10.

Authors:  Teresa L Capasso; Sara M Trucco; Morgan Hindes; Tristin Schwartze; Jamie L Bloch; Jacqueline Kreutzer; Stephen C Cook; Cynthia S Hinck; Davide Treggiari; Brian Feingold; Andrew P Hinck; Beth L Roman
Journal:  Am J Respir Crit Care Med       Date:  2021-01-15       Impact factor: 21.405

Review 4.  Approaches to treat pulmonary arterial hypertension by targeting BMPR2: from cell membrane to nucleus.

Authors:  Benjamin J Dunmore; Rowena J Jones; Mark R Toshner; Paul D Upton; Nicholas W Morrell
Journal:  Cardiovasc Res       Date:  2021-09-28       Impact factor: 10.787

5.  Homozygous GDF2 nonsense mutations result in a loss of circulating BMP9 and BMP10 and are associated with either PAH or an "HHT-like" syndrome in children.

Authors:  Joshua Hodgson; Lidia Ruiz-Llorente; Jamie McDonald; Oliver Quarrell; Kelechi Ugonna; James Bentham; Rebecca Mason; Jennifer Martin; David Moore; Katie Bergstrom; Pinar Bayrak-Toydemir; Whitney Wooderchak-Donahue; Nicholas W Morrell; Robin Condliffe; Carmelo Bernabeu; Paul D Upton
Journal:  Mol Genet Genomic Med       Date:  2021-04-09       Impact factor: 2.183
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.